Wormannin treatment significantly reduced glioblastoma-derived EVs-induced PI3K-Akt upregulation, as demonstrated by reduced expressions of p-PI3K, p-Akt, and p-mTOR after Wortmannin treatment (Fig. 6). Here, MTOR is linked to glioblastoma.